Trauma and PTSD – An overlooked pathogenic pathway for Premenstrual Dysphoric Disorder? by Wittchen, Hans-Ulrich et al.
Trauma and PTSD – An overlooked pathogenic pathway for Premenstrual 
Dysphoric Disorder? 
 
H.-U. Wittchen, A. Perkonigg, and H. Pfister 
 
Technical University of Dresden, Institute of Clinical Psychology and Psychotherapy, Dresden, Germany 
and Max Planck Institute of Psychiatry, Munich, Germany 
 
 
 
Summary 
 
Background: A recent epidemiological analysis on premenstrual dysphoric disorder (PMDD) in the 
community revealed increased rates of DSM-IV posttraumatic stress disorder (PTSD) among women 
suffering from PMDD. Aims: To explore whether this association is artifactual or might have important 
pathogenic implications. 
Methods: Data come from a prospective, longitudinal community survey of an original sample of N¼1488 
women aged 14–24, who were followed-up over a period of 40 to 52 months. Diagnostic assessments are 
based on the Composite International Diagnostic Interview (CIDI) using the 12-month PMDD diagnostic 
module. Data were analyzed using logistic regressions (odds ratios) and a case-by-case review. 
Results: The age adjusted odds ratio between PTSD and threshold PMDD was 11.7 (3.0–46.2) at baseline. 
10 women with full PTSD and at least subthreshold PMDD were identified at follow-up. Most reported an 
experience of abuse in childhood before the onset of PMDD. Some had experienced a life-threatening 
experience caused by physical attacks, or had witnessed traumatic events experienced by others. 3 women 
reported more than one traumatic event. 
Conclusions: A case-by-case review and logistic regression analyses suggest that women with traumatic 
events and PTSD have an increased risk for secondary PMDD. These observations call for more in-depth 
analyses in future research. 
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Introduction 
 
The existence of cyclically recurring premenstrual symptoms of clinical significance has been 
recognised for decades, and has been labelled premenstrual syndrome (PMS). Subsequent studies 
in clinical settings and a few in the community have underlined that PMS symptoms are 
widespread, with significant attendant clinical, public health and socio-economic implications. 
(Logue and Moos, 1988; Woods et al., 1982). More stringent attempts to define and 
operationalize diagnostic criteria for severe premenstrual conditions, however, have been a more 
recent event. The revised 3
rd
 edition of DSM (DSM-III-R; APA, 1987) suggested in its appendix 
for conditions requiring further study, the category of late luteal phase dysphoric disorder 
(LLPDD) for severe forms of PMS with criteria predominantly characterized by mood symptoms. 
In DSM-IV (APA, 1994) the diagnosis was retained under the name ‘‘Premenstrual Dysphoric 
Disorder (PMDD) in the appendix, with more refined and slightly different criteria along with the 
suggestion to diagnose and code this condition as ‘‘depressive disorders not otherwise 
specified’’. Despite an abundance of clinical research on premenstrual and menstrual symptoms, 
there are only few reliable and comprehensive epidemiological data available that do provide 
estimates about the prevalence, incidence, risk factors and correlates of both LLPDD and PMDD 
in the community and in clinical settings. In particular, data on patterns of comorbidity are rare. 
Most of the available epidemiological evidence is confined to numerous studies that used 
questionnaire data to describe the frequency and the type of PMS symptoms as well as selected 
correlates in both adolescent and adult women (Van Keep and Lehert, 1981; Logue and Moos, 
1986; Johnson, 1987; Johnson et al., 1988; Cleckner-Smith et al., 1998; Monagle et al., 1993; 
Ramcharan et al., 1992). Despite considerable variation in instruments, sampling and design of 
these studies, there is considerable evidence that the vast majority of women have at least some 
PMS symptoms. Yet, the prevalence of more severe PMS symptoms seems to be considerably 
lower. Estimates for variably defined severe PMS symptomatology vary between 1% and 9%. 
There are three community studies available that have used stricter epidemiological standards 
concerning PMS as a syndrome and that have provided prevalence estimates for clinically 
relevant PMS conditions. Results from the Zurich cohort studies (Merikangas et al., 1993; Angst 
et al., 2001) suggest that according to their study instrument 8.1% could be regarded as having 
severe and 13.6% as having moderate perimenstrual syndromes in their community cohort of 299 
women, aged 21 to 35. Deuster et al. (1999) have performed the most powerful survey in the 
community to date. Using telephone interview survey data incorporating the administration of the 
Menstrual Distress Questionnaire in a sample of 874 women in Virginia, US, they reported a 
crosssectional prevalence of 8.3% (95 confidence interval 6.4%–10.2%) for females aged 18–44. 
This study is also the only one examining associations between a number of social and 
behavioural factors including nutritional, physical exercise, stress and affective state. The third 
and the most recent study is the Early Developmental Stages of Psychopathology Study (EDSP), 
a prospectivelongitudinal community survey in Munich, Germany (Wittchen et al., 2002). 
Findings from the EDSP revealed a 12-month prevalence of 5.8% of DSM-IV PMDD and an 
additional 18.6% with ‘‘near-threshold’’ PMDD among younger women aged 14–24 years old at 
baseline. The cumulative incidence after 42 months was 7.4%. 12-month and lifetime 
comorbidity of PMDD with other mental disorders namely anxiety disorders 47.4%, mood 
disorders 22.9%, somatoform disorders 28.4% were high and the unexpectedly strong association 
between posttraumatic stress disorder (PTSD) and PMDD was particularly noteworthy. Because 
of the strength of this association and the potential pathogenic implications, the present study will 
explore this association in greater detail, by examining:  
1. whether this association is artifactual and  
2. the temporal patterns of PMDD and PTSD by means of case-by-case review.  
 
 
Methods  
 
The Early Developmental Stages of Psychopathology Study (EDSP) has been described in 
greater detail elsewhere (Lieb et al., 2000;Wittchen et al., 1998a, b). Briefly, the study is based on 
a 4-year prospective-longitudinal design with up to three assessment points (approximately 20 
months apart). As part of a representative community sample of N¼3021, adolescents and young 
adults living in the Munich area, at baseline (T0) in 1995, N¼1488 females aged 14 to 24 years 
were enrolled. For all subjects written informed consent was obtained. Due to the requirement of 
stable menstruation patterns, only 1091 (73.3%) women completed the PMS assessment at 
baseline (T0). At the first follow-up (T1), only the younger cohort aged 14–17 at baseline was 
contacted. N¼586 (99.2%) out of the total of 591 females completed the PMS assessment. At the 
second follow-up (T2), among all baseline participants recontacted, N¼1233 (99.5%) out of 1251 
women completed the PMS assessment an average of 42 months after T0. Baseline and follow-up 
sociodemographic characteristics of this representative German community sample have been 
reported in the previous PMDD-paper (Wittchen et al., 2002).  
 
Assessment of adolescents and young adults  
In all three waves of investigation, symptom and diagnostic assessment were based on the 
computer-assisted version of the Munich-Composite International Diagnostic Interview (MCIDI; 
Wittchen and Pfister, 1997). The M-CIDI allows for the standardized assessment of symptoms, 
syndromes and diagnoses of a wide range of DSM-IV substance use and mental disorders along 
with information about onset, duration, clinical and psychosocial severity1. Detailed information 
of the M-CIDI has already been described elsewhere (Wittchen et al., 1998a). Detailed analyses 
covering validity and reliability of single diagnostic criteria and age-, frequency- and quantity-
information have also been provided elsewhere (Reed et al., 1998; Wittchen et al., 1998b). In the 
baseline investigation, the lifetime version of the M-CIDI was used to assess lifetime and 12-
month information. For the two follow-up investigations, the M-CIDI was modified to cover the 
12-month period prior to the follow-up interview as well as the remaining interval between the 
investigations (12-month-interval-version).  
 
Assessment of PTSD  
Posttraumatic stress disorder as well as all other disorders is defined here as one meeting DSM-
IV criteria per the M-CIDI diagnostic algorithm. Details have been presented elsewhere 
(Perkonigg et al., 2000). Briefly, to match DSM-IV criteria and to take into account more recent 
methodological innovations, the PTSD module consisted of a screening question and a 
respondent list with 10 groups of specified events, an openended question about any other 
traumatic events to avoid speaking about embarrassing and stigmatising traumas, a question for 
each event for the DSM-IV A2 criterion (intense fear, helplessness, or horror) and further probing 
for the most severe events as well as linkages between events. The latter was used to determine 
exactly the number of qualifying events. Ten traumatic event types plus the open category were 
presented on the list: horrific experience during war, being imprisoned, or taken hostage or 
kidnapped, physical attacks and threats, sexual abuse, rape, serious accidents, experience of 
natural catastrophes, sudden (threat of) death of associates and witnessing traumatic events 
experienced by others. If the respondent indicated several qualifying events (A1 and A2 criterion: 
events involving actual or threatened death or serious injury, or a threat to the physical integrity 
of self or others and a response with intense fear, helplessness, or horror) that did not cluster, 
DSM-IV criteria for the worst and most distressing event were assessed with all DSM-IV criteria 
questions. One-week test-retest reliability of PTSD is acceptable (kappa¼0.79) as was the 
validity (kappa¼0.85).  
 
M-CIDI-PMDD module  
In addition to the information concerning the respondents’ menstruation history, anthropometrical 
information as well as contraceptives use, each wave included an identical assessment of 
premenstrual syndromes according to criteria of DSM-IV PMDD. The PMDD module was only 
administered in females with at least 3 years’ history of regular menstruation and consisted of a 
series of questions pertaining to the past 12 months: a) 11 questions to evaluate the presence of 
DSM-IV symptom criteria during the past 12 months, respectively their presence during the 
majority of all menstrual cycles in the past 12 months (DSM-IV criteria A), b) one question to 
ascertain whether these symptoms occur consistently in the week before onset of menstruation 
                                                 
1
The complete M-CIDI is available on request. 
(A), c) as well as three questions to evaluate criterion B for impairment and psychosocial 
interference. There was no PMDD specific assessment for criterion C (differential diagnostic 
criteria) nor of criterion D (prospective ratings). Besides this DSM-IV PMDD threshold diagnosis 
(without criteria C and D) we also specified a subthreshold PMDD diagnosis defined by falling 
short of just one of the several other DSM-IV criteria.  
 
Weighting of data and statistical analysis  
As the EDSP is designed with special interest in early stages of psychopathology, 14- to 15-year-
olds were sampled at twice this probability of 16- to 21-year-olds, and 22- to 24-year-olds were 
sampled at half this probability. This sampling strategy allows particularly precise estimations of 
measures used for comparative analyses for the age group of primary interest, i.e., 14- to 15-year-
olds. Due to the different sampling probabilities, relative weights inversely proportional to the 
sampling fraction are used in the estimation of measures that are generalized to the sampling 
frame. In addition, these weights also account for nonresponse according to age and geographic 
distribution (urban vs. rural) of the respondents to that of the registered sampling frame. The 
Stata Software package (Stata Corp., 1999) was used to calculate proportions and standard errors 
as well as robust confidence intervals for weighted data. Logistic regressions controlling for age 
with odds ratios (OR) were used to describe associations between other 12-month DSM-IV 
baseline disorders and threshold PMDD as well as subthreshold PMDD. An OR of 1.0 or 
indistinguishable from 1.0 as bounded by the 95% confidence interval is hereby considered as 
insignificant.  
 
 
Results  
 
Associations of other disorders and PTSD with PMDD  
Table 1 reports the frequency of other selected mental disorders and especially PTSD among 
non-PMDD cases and compares their rates to the frequencies among threshold and subthreshold 
PMDD cases. These comparisons result in an OR which should be distinguishable from 1.0 if 
there is any association. Most frequent significant associations were between threshold PMDD 
and (a) anxiety disorders (OR¼3.1; CI, 1.7–5.5), (b) all mood disorders (OR¼3.0; CI, 1.6–5.7), 
including bipolar I and II, and (c) somatoform disorders (pain, and SSI-4=6; OR¼3.4; CI, 1.8–
6.6). Among anxiety disorders, the strongest association was found with PTSD (OR¼11.7; CI, 
3.0–46.2). Associations of subthreshold PMDD appear to be relatively similar, however the 
associations were generally weaker and due to the lower number of PTSD cases and the higher 
number of subthreshold PMDDs, this association was not significant. Not shown in Table 1, we 
further examined whether baseline PTSD predicted the onset of PMDD during the follow-up 
period. While we found 13.8% of women with PTSD among new threshold PMDD cases 
resulting in a significant OR of 8.7 (1.3–57.9) PTSD was not significantly associated with 
subthreshold PMDD (OR¼0.2; CI, 0.0–1.4).  
 
Case by case review of PMDD and PTSD cases  
At baseline and first follow-up 10 women fulfilled DSMIV criteria for PTSD and had suffered 
from threshold or subthreshold PMDD. A case by case review of these 10 women showed the 
following pattern up to the second follow-up: Five women with full PTSD at baseline had been 
abused or reported a rape. All 5 women had also suffered from threshold PMDD. 3 of them had 
an early age at trauma between 11 and 12 years, which precedes PMDD symptoms. At the second 
follow-up, one of them still reported symptoms qualifying for threshold PMDD 13 years after the 
trauma. Another one still reported subthreshold PMDD at the second follow-up. One woman with 
a preceding abuse experience did not fulfil criteria of subthreshold or threshold PMDD. The 
remaining two women reported no symptoms or had dropped out by the follow-up investigation. 
Three women fulfilled our criteria of subthreshold PMDD at baseline. One of them had been 
raped later during follow-up and suffered from full PMDD at follow-up. The second woman with 
subthreshold PMDD at baseline reported of a threat trauma after or at the same time as the onset 
of subthreshold PMDD, and the third had experienced multiple traumas with an earlier onset at 
the age of 11. At the second follow-up investigation, this woman fulfilled criteria for threshold 
PMDD. Findings for primary traumatic events also came from two women who reported an 
earlier age at abuse and rape before baseline at the age of 12 and 15 years and had suffered from 
PMDD after baseline, assessed at the first follow-up at the age of 18 years. Findings for other 
types of events preceding PMDD are unclear. Threat events also preceded PMDD in two women 
at the age of 12 and 14 years, but one of them had reported a rape at the age of 15. Witnessing 
traumatic events experienced by others also seem to precede but were only reported by women 
who had experienced more than one trauma.  
 
 
Discussion  
 
This is to our knowledge the first epidemiological study demonstrating associations between 
PMDD and PTSD. The fact that these associations were confirmed in prospective longitudinal 
follow-ups, and were also sustained in case-by-case reviews, lends further support to the 
possibility that this association might bear important nosological implications. To our knowledge, 
this association has not been examined in great detail until now. There are a small number of 
clinical studies among sexually abused women (Girdler et al., 1998; Golding et al., 2000) that 
showed that many abused women had symptoms of PMDD. Golding et al. (2000) also reported 
that these women were abused earlier in life, more frequently and by similar types of offenders. 
But no previous study has used strict diagnostic criteria in a large community study, based on a 
standardized diagnostic interview, instead of questionnaires. Furthermore, a broader range of 
traumatic events qualifying for PTSD has not been studied. Our prospective-longitudinal design 
allowed us to show that there might be causal effects of traumatic events on PMDD. The fact that 
the majority of triggering traumatic events leading to PTSD appears before menstruation started 
supports this speculation. Further, indirect support comes from our previous analyses on incident 
comorbid conditions (Wittchen et al., 2002), suggesting that after the onset of PMDD, women 
reveal a decreased risk for further incident anxiety disorders as well as no elevated risk for PTSD 
and traumatic events. Still, the specificity of effects of traumatic events for PMDD is unclear. 
Comorbidity rates of both PMDD and PTSD with other mental disorders and also other physical 
symptoms (McCauley et al., 1997) are high and one might speculate a nonspecific dysregulation 
of the stress response in association with traumatic events, which might also influence 
menstruation. In further research into our prospective data we will include more complex models 
with a broader range of preceding factors to clarify the role of traumatic events and PTSD in 
PMDD. Among the limitations of the study, one should keep in mind that traumatic event reports 
might be influenced by recall bias and could also have influenced self-ratings of PMDD. 
Furthermore, in diagnosing PMDD we did not take into account all diagnostic exclusions and we 
were also unable to fulfil the DSM-IV requirement of using prospective diaries across at least 2 
menstrual cycles. Another important limitation of the study is that we exclusively examined 
PMDD cases aged 14–24 years at baseline, and followed them up over a period of 38 months. 
Thus, the results refer to adolescents and young adults and not to women above this age cut-off, 
for which a second high incidence period after the age of 35 has been suggested in previous 
literature. It is also noteworthy that the number of cases especially with both full threshold PTSD 
and PMDD is relatively small. 
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